HHS Secretary Robert F. Kennedy Jr. defended the FDA and Commissioner Marty Makary during a House hearing on Thursday morning, saying that Makary is under

OpenAI is the latest tech giant to move into biopharma, announcing a life sciences-focused AI offering on Thursday. The San Francisco-based company announced GPT-Rosalind, effectively

A new report trying to settle a decades-old debate about Alzheimer’s disease has reached a dramatic conclusion: Antibody drugs that target sticky amyloid beta proteins

Roche said it will run a new Phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in another attempt to win approval

If you asked me a year ago to break down the different areas of healthcare AI we’re covering, it might’ve looked like scribes, clinical decision